ORIC Pharmaceuticals, Inc.ORICNASDAQ
Loading
Year-over-year book value per share growth
| Period | Value |
|---|---|
| Q4 2025 | 6.46% |
| Q3 2025 | -0.84% |
| Q2 2025 | 34.07% |
| Q1 2025 | -10.11% |
| Q4 2024 | -11.41% |
| Q3 2024 | -9.64% |
| Q2 2024 | -11.91% |
| Q1 2024 | 25.13% |
| Q4 2023 | -9.53% |
| Q3 2023 | -26.79% |
| Q2 2023 | 30.90% |
| Q1 2023 | -18.83% |
| Q4 2022 | 2.09% |
| Q3 2022 | -9.53% |
| Q2 2022 | -6.52% |
| Q1 2022 | -7.85% |
| Q4 2021 | -6.81% |
| Q3 2021 | 6.18% |
| Q2 2021 | -6.49% |
| Q1 2021 | -12.68% |
| Q4 2020 | 41.72% |
| Q3 2020 | -32.63% |
| Q2 2020 | 118.24% |
| Q1 2020 | -210.69% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |